AGA/AASLD
- DateMay 21, 2024SOCIETY: AGA/AASLD
Moderators
Indiana UniversityUniversity of Arkansas for Medical Sciences - DateMay 21, 2024BACKGROUND/AIM: The objective of this study is to assess the long-term efficacy of ursodeoxycholic acid (UDCA) in preventing gallstone formation after gastrectomy in patients with gastric cancer…
- DateMay 21, 2024Background: Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are integral in managing type 2 diabetes. However, their long-term impact on gastrointestinal and hepatobiliary health remains uncertain…
Presenter
Speakers
- DateMay 21, 2024Cardiovascular disease (CVD) remains a leading cause of death in women. The Atherosclerotic Cardiovascular Disease 10-year risk score recommended by the American College of Cardiology does not encompass chronic inflammatory diseases, which is associated with increased CVD risk…
Presenter
Speakers
- DateMay 21, 2024BACKGROUND: PSC is a chronic inflammatory condition of the biliary epithelium characterized by concentric periductal fibrosis. As opposed to inflammatory bowel disease (IBD), a frequently overlapping trait, there are currently no drugs that definitively slow disease progression…
Presenter
Speakers
- DateMay 21, 2024Ferroptosis plays an important role in the pathogenesis of various liver diseases, yet it has rarely been investigated in human autoimmune hepatitis (AIH)…
Presenter
- DateMay 21, 2024INTRODUCTION: Coexistence of metabolic dysfunction-associated liver disease (MASLD) and autoimmune hepatitis (AIH) could lead to more severe disease with poorer outcomes…
Presenter
Speakers
Indiana University School of MedicineIndiana University